No Data Available
Kabra Drugs Share Price
BSE
Loading...
| Open | - |
| High | - |
| Low | - |
| Prev Close | - |
| Volume | - |
| VWAP(₹) | - |
Key Metrics
| PE Ratio(x) | 11.07 |
| EPS - TTM(₹) | 2.10 |
| MCap(₹ Cr.) | 54.98 |
| MCap Rank | 151 |
| PB Ratio(x) | 1.76 |
| Div Yield(%) | - |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 35.52 |
| 52W Low(₹) | 12.21 |
| MCap/Sales | 0.63 |
| Beta(1 Month) | 0.29 |
| BV/Share(₹) | 12.49 |
Kabra Drugs share price insights
ROE Outperforming 5 Year Average
Company delivered ROE of 16.74% in year ending Mar 31, 2026 outperforming its 5 year avg. of 4.82%. (Source: Standalone Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 1.58% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)Kabra Drugs Share Price Update
Kabra Drugs Ltd. share price moved up by 8.21% from its previous close of Rs 21.43. Kabra Drugs Ltd. stock last traded price is 23.19
Share Price Value Today/Current/Last 23.19 Previous Day 21.43
Found Insights useful?
Kabra Drugs Share Price Returns
| 1 Day | 8.21% |
| 1 Month | -10.98% |
| 3 Months | -19.87% |
| 1 Year | N.A. |
| 3 Years | N.A. |
| 5 Years | N.A. |
Kabra Drugs Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
News & Analysis
Revised Receipt Of Letter Of Intent From Chhattisgarh Government For Proposed Investm..
AnnouncementsReceipt Of Letter Of Intent From Chhattisgarh Government For Proposed Investment Of ?..
AnnouncementsShareholder Meeting / Postal Ballot-Scrutinizer"s Report
AnnouncementsShareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Announcements
Financials
Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Total Income 35.52 30.60 19.94 7.17 0.64 Total Income Growth (%) 16.06 53.46 178.29 1,019.37 - Total Expenses 34.08 28.00 17.74 7.67 0.25 Total Expenses Growth (%) 21.72 57.86 131.38 2,997.41 -53.84 EBIT 1.44 2.60 2.21 -0.50 0.39 EBIT Growth (%) -44.87 18.05 - -227.30 - Profit after Tax (PAT) 1.06 2.57 1.84 -0.50 0.39 PAT Growth (%) -58.56 39.73 - -226.97 - EBIT Margin (%) 4.04 8.51 11.06 -6.98 61.34 Net Profit Margin (%) 2.99 8.39 9.21 -6.98 61.50 Basic EPS (₹) 0.45 1.08 0.77 -0.21 0.21 All figures in Rs Cr, unless mentioned otherwise
InsightsEmployee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 1.58% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Total Assets 86.27 25.23 4.57 0.70 0.73 Total Assets Growth (%) 241.93 452.08 552.86 -4.11 -47.86 Total Liabilities 56.66 0.57 3.49 1.43 1.12 Total Liabilities Growth (%) 9,840.35 -83.67 144.06 27.68 -30.43 Total Equity 29.61 24.65 1.08 -0.73 -0.39 Total Equity Growth (%) 20.12 2,182.41 - - - Current Ratio (x) 1.49 43.84 1.30 0.47 0.63 Total Debt to Equity (x) 0.01 0.02 -1.16 -1.89 -2.61 Contingent Liabilities 0.00 0.49 - - - All figures in Rs Cr, unless mentioned otherwise
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Net Cash flow from Operating Activities -9.47 -4.71 -0.21 -0.35 -0.13 Net Cash used in Investing Activities -1.36 -0.05 - - - Net Cash flow from Financing Activities 0.12 23.39 2.88 0.36 0.13 Net Cash Flow -10.72 18.63 2.67 0.00 -0.01 Closing Cash & Cash Equivalent 10.58 21.30 2.67 0.00 0.00 Closing Cash & Cash Equivalent Growth (%) -50.32 697.44 0.01 133.67 -87.10 Total Debt/ CFO (x) -0.05 -0.09 -8.19 -3.90 -7.67 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Return on Equity (%) 16.74 -4.40 0.00 0.00 0.00 Return on Capital Employed (%) 19.34 -4.40 -67.97 46.22 47.15 Return on Assets (%) 5.74 -4.30 -16.10 -48.02 -25.40 Interest Coverage Ratio (x) 194.06 0.00 0.00 0.00 0.00 Asset Turnover Ratio (x) 1.66 - - - - Price to Earnings (x) 11.75 -24.27 -4.29 -7.25 -10.79 Price to Book (x) 1.97 1.07 -2.15 -3.35 -5.08 EV/EBITDA (x) 8.27 -5.02 -2.98 -11.32 -17.22 EBITDA Margin (%) 6.27 0.00 0.00 0.00 0.00 InsightsROE Outperforming 5 Year Average
Company delivered ROE of 16.74% in year ending Mar 31, 2026 outperforming its 5 year avg. of 4.82%. (Source: Standalone Financials)
Found Financials useful?
Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
Mutual Funds Ownership
No Data Available
Kabra Drugs Top Searches
Corporate Actions
Board Meeting
Quarterly Results
May 21, 2026
General Meeting
-
May 08, 2026
Board Meeting
Others
Apr 27, 2026
Announced on Meeting on May 21, 2026 May 29, 2026 Quarterly Results Apr 27, 2026 May 06, 2026 Others Apr 10, 2026 Apr 21, 2026 Others Feb 26, 2026 Mar 07, 2026 Others Feb 06, 2026 Feb 13, 2026 Quarterly Results No Data Available
No Data Available
No Data Available
No Data Available
Announced on Meeting on May 08, 2026 Jun 12, 2026 - Dec 03, 2025 Dec 26, 2025 - Sep 16, 2025 Sep 30, 2025 - Dec 11, 2024 Jan 02, 2025 - Sep 03, 2024 Sep 30, 2024 A.G.M.
About Kabra Drugs
Industry
Key Indices Listed On
-
Address
208, Swadesh Bhavan,2 Press Complex, AB Road,Indore, Madhya Pradesh - 452011
Executive Leadership
NA
N Aravind
Managing DirectorBV
Bangalore Venkatakrishnappa Ananth Kumar
WholeTime Director & CFOKN
Kuniamuthur Nanjappan Anand
Executive DirectorAA
A Anitha
Independent DirectorShow More
Auditors
PPN & Co.
Rishi Sekhri & Associates
Pawan Shikar Jain & Associates
FAQs about Kabra Drugs share
- 1. What is Kabra Drugs share price and what are the returns for Kabra Drugs share?As on 12 Jun, 2026, 03:45 PM IST Kabra Drugs share price is up by 8.21% basis the previous closing price of Rs 21.46. Kabra Drugs share price is Rs 23.19.
- 2. What is the PE & PB ratio of Kabra Drugs?The PE ratio of Kabra Drugs stands at 10.5, while the PB ratio is 1.76.
- 3. What is Kabra Drugs's 52 week high / low?In last 52 weeks Kabra Drugs share had a high price of Rs 35.52 and low price of Rs 12.21
- 4. What's the market capitalization of Kabra Drugs?Market Capitalization of Kabra Drugs stock is Rs 54.98 Cr.
Top Gainers
As on 04:06 PM | 12 Jun 2026Top Losers
As on 03:58 PM | 12 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.